Sign in

CIK 0001641281 · <br>Emerging growth company

Bolt Biotherapeutics, Inc.

Sign in to watch
Ticker
BOLT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472804636
Phone
650-665-9295
Business address
900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
Bolt Therapeutics, Inc.
Open-market buys, last 90 days
$319,000
in 1 filing
Open-market sales, last 90 days
$128,281
in 3 filings

Net +$190,719. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-03-24 HEALY JAMES Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2022-02-18 Perez Edith A. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +210,000 210,000
2022-02-18 Yonehiro Grant Chief Business Officer Grant or award · Stock Option (Right to Buy) +190,000 190,000
2022-02-18 Quinn William P. Chief Financial Officer Grant or award · Stock Option (Right to Buy) +210,000 210,000
2022-02-18 Dornan David Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +210,000 210,000
2022-02-18 Schatzman Randall C Chief Executive Officer Grant or award · Stock Option (Right to Buy) +630,000 630,000
2021-12-22 Perez Edith A. Chief Medical Officer Option exercise +35,714 $2.80 $100K 37,042
2021-12-22 Perez Edith A. Chief Medical Officer Option exercise · Stock Option (Right to Buy) −35,714 189,286
2021-12-14 ONETTO NICOLE Director Grant or award · Stock Option (Right to Buy) +27,860 27,860
2021-12-08 Quinn William P. Chief Financial Officer Purchase +5,000 $4.72 $24K 20,154
2021-12-06 Perez Edith A. Chief Medical Officer Purchase +411 $4.64 $2K 1,328
2021-12-06 Quinn William P. Chief Financial Officer Purchase +35 $4.64 $162 15,154
2021-11-17 Lee Frank D. Director Grant or award · Stock Option (Right to Buy) +27,860 27,860
2021-11-17 O'CALLAGHAN BRIAN Director Grant or award · Stock Option (Right to Buy) +27,860 27,860
2021-06-04 Perez Edith A. Chief Medical Officer Purchase +917 $16.65 $15K 917
2021-06-04 Quinn William P. Chief Financial Officer Purchase +1,221 $16.65 $20K 15,119
2021-02-09 Novo Holdings A/S 10% owner Conversion +4,027,088 4,103,991
2021-02-09 Novo Holdings A/S 10% owner Purchase +400,000 $20.00 $8.0M 4,503,991
2021-02-09 Novo Holdings A/S 10% owner Conversion · SERIES A-1 PREFERRED STOCK −1,096,323 0
2021-02-09 Novo Holdings A/S 10% owner Conversion · SERIES B PREFERRED STOCK −2,050,758 0

Page 13 of 17 · 337 trades